Search clinical trials for: LP352

Total 3 results

Longboard Pharmaceuticals

Recruiting

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

Dravet Syndrome | Lennox-Gastaut Syndrome | Developmental and Epileptic Encephalopathy

United States, Australia
Longboard Pharmaceuticals

Available

Intermediate-Size Expanded Access Protocol (EAP) for LP352

Dravet Syndrome | Lennox Gastaut Syndrome | Developmental and Epileptic Encephalopathies

United States
Longboard Pharmaceuticals

Completed

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies (PACIFIC)

Dravet Syndrome | Lennox Gastaut Syndrome | Developmental and Epileptic Encephalopathy

United States, Australia

3

Subscribe